Gene therapy trial for inherited blindness halted early
Disease control
Terminated
This study tested a gene therapy for retinitis pigmentosa, a genetic eye disease that slowly leads to blindness. The treatment involved injecting a working copy of the faulty gene under the retina. The trial was stopped early, so results are limited, but the goal was to slow or s…
Phase: PHASE1, PHASE2 • Sponsor: eyeDNA Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC